Clinical Trial Update: Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on a neoadjuvant regimen combining pyrotinib with epirubicin and cyclophosphamide followed by taxanes and trastuzumab for HER-2–positive b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• Pyrotinib (pyrotinib)
• Taxanes (Taxane class)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING